Biocrates Life Sciences Raises €1.2M

Biocrates Life Sciences AG, an Innsbruck, Austria-based developer of metabolite biomarkers, has raised €1.2m in a financing round led by ARAX Capital Partners GmbH.
The company, which was founded in 2002, will use the funds to invest in biomarker research and close new strategic alliances.
A further funding of the same amount is expected by the end of the year.


Join the discussion